active ingredient: nabumetone; 1 tablet contains nabumetone 500 mg;
excipients: microcrystalline cellulose, corn starch, polysorbate 80, sodium lauryl sulfate, sodium starch (type A), colloidal silicon dioxide, talc, hypromellose, titanium dioxide (E 171), polyethylene glycol 6000, red iron oxide (E 172).
Means that affect the musculoskeletal system. Non-steroidal anti-inflammatory drugs. Nabumeton. ATX code M01A X01.
For the treatment of pain and inflammation in osteoarthritis and rheumatoid arthritis.
Dosage and administration:
The drug should be used by adults inside during or after meals.
The recommended starting dose is 500-750 mg once daily. The recommended daily dose is 1 g – 1 time per day at bedtime. In cases of severe or persistent symptoms, the dose may be increased to 1.5 – 2 g per day by adding one or two tablets (500 mg – 1 g) as the morning dose. The maximum daily dose is 2 g.
The drug should be used for a short time at the lowest effective dose necessary to control the symptoms of the underlying disease.
The duration of the course of treatment is determined by the doctor individually, depending on the effect achieved, the nature of the therapy and the tolerability of the drug.
In elderly patients, the drug may remain in the blood longer and the level of the drug may be higher, so the recommended daily dose of 1 g should not be exceeded, and in some cases one tablet (500 mg) may provide satisfactory relief.
Shelf life: 2 years
Produced in India